Dimeric Naphthalimide Formulation pH Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Dimeric naphthalimide compounds, such as Compound of Formula (I), degrade significantly at pH levels below 5 or above 7, and exhibit minimal impurity concentration increase only within a pH range of 5 to 7, posing challenges in formulation stability.
Innovation Solution
A composition comprising a dimeric naphthalimide active agent, pharmaceutically acceptable salts, a tonicity agent, a buffer, and a vehicle, formulated to maintain a pH between 5 and 7, thereby stabilizing the active agent and minimizing impurity formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the dimeric naphthalimide compound is formulated at pH levels below 5 or above 7, then the compound degrades significantly, but maintaining pH within 5 to 7 limits formulation flexibility
Solution Approach 1:
The patent applies parameter changes by establishing a specific pH range (5 to 7) as the optimal condition for compound stability. This involves adjusting the pH parameter to a narrow window that prevents degradation while maintaining compound integrity, thereby resolving the contradiction between stability and formulation flexibility.
Solution Approach 2:
The patent introduces buffer agents as intermediary substances that maintain the pH within the stable range of 5 to 7. These buffers act as mediators between the compound and the external environment, absorbing pH variations and ensuring the compound remains stable without requiring strict control of formulation pH.
2Object-generated harmful factors
If the dimeric naphthalimide compound is exposed to extreme pH conditions, then impurity concentration increases significantly, but controlling pH requires additional formulation components
Solution Approach 1:
The patent employs buffer agents as intermediary substances that prevent impurity formation by maintaining pH within the stable range. These buffers mediate between the compound and extreme pH conditions, absorbing the harmful effects without requiring complex formulation systems.
Solution Approach 2:
The patent converts the potential harm of pH variability into a benefit by using buffer agents that actively maintain pH within the optimal range. Instead of avoiding pH control entirely, the system uses buffers to ensure pH remains stable, thereby preventing impurity formation while simplifying formulation.
3Stability of the object's composition
If the dimeric naphthalimide compound is formulated with strict pH control, then compound integrity is maintained, but formulation simplicity is reduced
Solution Approach 1:
The patent applies self-service by using buffer agents that automatically maintain pH within the stable range without requiring external intervention. The buffers self-regulate the pH environment, ensuring compound integrity while simplifying the formulation process compared to strict manual pH control.
Solution Approach 2:
The patent introduces buffer agents as intermediary substances that handle pH control automatically. These buffers act as mediators that maintain compound integrity by ensuring pH remains within the optimal range, thereby reducing the complexity of formulation while maintaining stability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation effectively stabilizes the dimeric naphthalimide compound, maintaining its integrity and reducing impurity concentration within the specified pH range, ensuring predictable concentration and safety for administration.
Implementation Method 1
a buffer, and a vehicle, formulated to maintain a pH between 5 and 7, thereby stabilizing the active agent and minimizing impurity formation
Data Source
AI summary
The present disclosure provides novel formulations for dimeric naphthalimides and stability studies of the same. In some embodiments, the dimeric naphthalimide is a diacetate salt of Compound of Formula (I).